What 8 Analyst Ratings Have To Say About Insulet
Portfolio Pulse from Benzinga Insights
Over the past quarter, Insulet (NASDAQ:PODD) received 8 analyst ratings, with 1 bullish, 5 somewhat bullish, and 2 indifferent. The average 12-month price target for Insulet is $212.25, with a high of $250.00 and a low of $162.00. This average has decreased by 20.63% from the previous average price target of $267.43. Analysts rate stocks based on company financials, meetings, and insider information, providing guidance to investors.
December 04, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Insulet has received mostly positive ratings from analysts, with a decrease in the average price target suggesting a more cautious outlook on the stock's future performance.
The majority of analysts have given Insulet a somewhat bullish rating, indicating a generally positive sentiment. However, the decrease in the average price target may temper expectations for the stock's short-term growth potential. The ratings are a key driver of investor sentiment and can influence stock price, but the reduction in the target price suggests that while the outlook remains positive, it may not be as strong as it was previously.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100